Pfizer Inc. is a global biopharmaceutical leader engaged in the research, development, production, marketing, and distribution of a wide array of medicinal and vaccine products worldwide. Its comprehensive portfolio addresses diverse therapeutic areas, including cardiovascular health and women's health, featuring key brands such as the Premarin family and Eliquis. The company also offers advanced biologics, small molecule drugs, immunotherapies, and biosimilars for various conditions, exemplified by Ibrance, Xtandi, and Retacrit. Furthermore, Pfizer provides sterile injectables, anti-infective agents, and a significant oral treatment for COVID-19, including Paxlovid. A substantial portion of its offerings comprises vaccines for infectious diseases such as pneumococcal and meningococcal disease, tick-borne encephalitis, and COVID-19, with notable products like Comirnaty and the Prevnar family. The firm also develops biosimilars for chronic autoimmune and inflammatory disorders, including Inflectra and Xeljanz, alongside specialized therapies for rare conditions like amyloidosis, hemophilia, and endocrine disorders, under brands such as Vyndaqel and BeneFIX. Beyond its proprietary products, Pfizer operates a contract manufacturing division. Its extensive customer base includes wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, individual medical practices, and public health organizations. The company actively fosters strategic collaborations with numerous partners, such as Bristol-Myers Squibb Company, BioNTech SE, and Merck KGaA. Established in 1849, Pfizer Inc. is headquartered in New York, New York.
前收盤價
US$27.40
−US$0.14 · -0.51%
盤中時間採用ET。市場資料可能有所延遲。
Pfizer Inc. is a global biopharmaceutical leader engaged in the research, development, production, marketing, and distribution of a wide array of medicinal and vaccine products worldwide. Its comprehensive portfolio addresses diverse therapeutic areas, including cardiovascular health and women's health, featuring key brands such as the Premarin family and Eliquis. The company also offers advanced biologics, small molecule drugs, immunotherapies, and biosimilars for various conditions, exemplified by Ibrance, Xtandi, and Retacrit. Furthermore, Pfizer provides sterile injectables, anti-infective agents, and a significant oral treatment for COVID-19, including Paxlovid. A substantial portion of its offerings comprises vaccines for infectious diseases such as pneumococcal and meningococcal disease, tick-borne encephalitis, and COVID-19, with notable products like Comirnaty and the Prevnar family. The firm also develops biosimilars for chronic autoimmune and inflammatory disorders, including Inflectra and Xeljanz, alongside specialized therapies for rare conditions like amyloidosis, hemophilia, and endocrine disorders, under brands such as Vyndaqel and BeneFIX. Beyond its proprietary products, Pfizer operates a contract manufacturing division. Its extensive customer base includes wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, individual medical practices, and public health organizations. The company actively fosters strategic collaborations with numerous partners, such as Bristol-Myers Squibb Company, BioNTech SE, and Merck KGaA. Established in 1849, Pfizer Inc. is headquartered in New York, New York.
日內區間
目前US$27.40
52週區間
目前US$27.40
盤中時間採用ET。市場資料可能有所延遲。
Pfizer Inc. is a global biopharmaceutical leader engaged in the research, development, production, marketing, and distribution of a wide array of medicinal and vaccine products worldwide. Its comprehensive portfolio addresses diverse therapeutic areas, including cardiovascular health and women's health, featuring key brands such as the Premarin family and Eliquis. The company also offers advanced biologics, small molecule drugs, immunotherapies, and biosimilars for various conditions, exemplified by Ibrance, Xtandi, and Retacrit. Furthermore, Pfizer provides sterile injectables, anti-infective agents, and a significant oral treatment for COVID-19, including Paxlovid. A substantial portion of its offerings comprises vaccines for infectious diseases such as pneumococcal and meningococcal disease, tick-borne encephalitis, and COVID-19, with notable products like Comirnaty and the Prevnar family. The firm also develops biosimilars for chronic autoimmune and inflammatory disorders, including Inflectra and Xeljanz, alongside specialized therapies for rare conditions like amyloidosis, hemophilia, and endocrine disorders, under brands such as Vyndaqel and BeneFIX. Beyond its proprietary products, Pfizer operates a contract manufacturing division. Its extensive customer base includes wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, individual medical practices, and public health organizations. The company actively fosters strategic collaborations with numerous partners, such as Bristol-Myers Squibb Company, BioNTech SE, and Merck KGaA. Established in 1849, Pfizer Inc. is headquartered in New York, New York.
日內區間
目前US$27.40
52週區間
目前US$27.40
獲利能力占已公布營收的百分比。
營收
營業利益
淨利
| 項目(USD) | 2025會計年度 | 2024會計年度 | 2023會計年度 | 2022會計年度 | 2021會計年度 |
|---|---|---|---|---|---|
| 營收 | 625.79億 USD | 636.27億 USD | 595.54億 USD | 1011.75億 USD | 812.88億 USD |
| 銷貨成本 | 160.67億 USD | 178.51億 USD | 249.54億 USD | 343.44億 USD | 308.21億 USD |
| 毛利 | 465.12億 USD | 457.76億 USD | 346億 USD | 668.31億 USD | 504.67億 USD |
| 研究與開發 | 104.37億 USD | 108.22億 USD | 106.79億 USD | 114.28億 USD | 138.29億 USD |
| 銷售、一般及管理費用 | 137.94億 USD | 147.3億 USD | 147.71億 USD | 136.77億 USD | 127.03億 USD |
| 營業費用 | 291.05億 USD | 308.38億 USD | 301.83億 USD | 287.14億 USD | 302.32億 USD |
| 利息收入 | 6.03億 USD | 5.45億 USD | 16.24億 USD | 2.51億 USD | 3600萬 USD |
| 利息支出 | 26.71億 USD | 30.91億 USD | 22.09億 USD | 12.38億 USD | 12.91億 USD |
| 折舊和攤銷 | 65.92億 USD | 70.13億 USD | 62.9億 USD | 50.64億 USD | 51.91億 USD |
| 營業利益 | 174.07億 USD | 149.38億 USD | 44.17億 USD | 381.17億 USD | 202.35億 USD |
| 淨利 | 77.71億 USD | 80.31億 USD | 21.19億 USD | 313.72億 USD | 219.79億 USD |
公司資料更新於 2026年11月22日。
近期已公布業績
近期已公布業績
第三方分析師預期可能變動,並非 GoAI 建議。
報告持有此股票曝險的交易所交易基金。
State Street SPDR S&P 500 ETF1557.T3029.6億0.25%119.91兆 JPY0.09%¥113,700-3.19%
Vanguard S&P 500 ETFVOO46.23億0.27%1兆 USD0.03%US$635.54-3.41%
Vanguard Morningstar Total Stock Market ETFVTI43.59億0.24%6893億 USD0.03%US$340.02-3.52%
iShares Core S&P 500 ETFIVV21.15億0.25%8034.1億 USD0.03%US$693.71-3.52%
State Street SPDR S&P 500 ETFSPY19.11億0.25%7563.79億 USD0.09%US$689.81-3.64%
Vanguard Morningstar Value ETFVTV16.72億0.63%1959億 USD0.03%US$214.22-1.62%
State Street Health Care Select Sector SPDR ETFXLV11.45億2.44%469.2億 USD0.08%US$177.24-0.12%
Vanguard High Dividend Yield ETFVYM7.07億0.70%833億 USD0.04%US$153.87-2.06%
State Street SPDR S&P 500 ETF1557.T
Vanguard S&P 500 ETFVOO
Vanguard Morningstar Total Stock Market ETFVTI
iShares Core S&P 500 ETFIVV
State Street SPDR S&P 500 ETFSPY
Vanguard Morningstar Value ETFVTV
State Street Health Care Select Sector SPDR ETFXLV
Vanguard High Dividend Yield ETFVYMAI 生成內容及延遲市場資料僅供資訊與教育用途,不構成投資建議。